Nuveen’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Nuveen's ELV Position: Q3 2026 in Review
Nuveen increased its Elevance Health (ELV) stake by 53% in Q3 2026, buying an estimated $423M and bringing the position to 3,051,056 shares worth $1.19B. The position accounts for 0.28% of the portfolio, ranked #63.
Nuveen first reported a position in ELV in Q2 2013 and has held it in 54 quarters since. The position peaked at $1.61B in Q4 2022. 1,629 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Nuveen held 3,051,056 shares of Elevance Health worth $1.19B as of Q3 2026.
- Nuveen bought 1,061,193 Elevance Health shares in Q3 2026, an estimated $423M.
- Elevance Health made up 0.28% of Nuveen's portfolio in Q3 2026, its #63 holding.
- Nuveen first reported a position in Elevance Health in Q2 2013 and has held it in 54 quarters since.
- Nuveen's Elevance Health position peaked at $1.61B in Q4 2022.
- 1,629 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.